GlaxoSmithKline, Shionogi & Co., Ltd. Say HIV Drug Beats Gilead Sciences, Inc. Atripla in Test

An experimental treatment for HIV developed by GlaxoSmithKline Plc (GSK), Pfizer Inc. (PFE) (PFE) and Shionogi & Co. (4507) reduced the virus in more people than Gilead Sciences Inc. (GILD) (GILD)…
Read the full story: BioSpace.com Featured News